Positive ID

Biological Detection and Diagnostics

PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats for homeland defense, as well as analyze biological samples at the point of care.

Click here to view our products

Recent News

April 29, 2013
Photo Release -- PositiveID Corporation Launches Development of Firefly Dx to Confirm Biological Threats in the Field Within Minutes
more
April 22, 2013
PositiveID Corporation Announces Reverse Stock Split
more
March 25, 2013
PositiveID Corporation Publishes Report on Market Opportunities for M-BAND and Dragonfly
more
March 12, 2013
PositiveID Corporation Reviews 2012 Highlights and 2013 Outlook
more
February 20, 2013
PositiveID Corporation Announces License of iglucose Technology for Up to $2 Million
more
View Archives

PositiveID Corporation™ (OTCQB: PSID)

PositiveID Corporation™ is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid medical testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.

M-BAND

PositiveID specializes in airborne pathogen detection, rapid clinical diagnostics and sample preparation applications. more

Dragonfly

PositiveID has developed a series of cartridges for biological sample processing and detection. more

Firefly

PositiveID is developing a portable, handheld biological detection system. more

PositiveID™ Corporation, 2013 - All Rights Reserved